Analyst Price Targets — UHS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 22, 2026 10:53 am | — | Barclays | $262.00 | $203.68 | TheFly | Universal Health price target lowered to $262 from $263 at Barclays |
| January 7, 2026 1:47 pm | — | UBS | $245.00 | $214.97 | TheFly | Universal Health price target lowered to $245 from $251 at TD Cowen |
| January 7, 2026 10:38 am | — | Wells Fargo | $235.00 | $221.74 | TheFly | Universal Health downgraded to Equal Weight from Overweight at Wells Fargo |
| December 2, 2025 12:25 pm | Jason Cassorla | Guggenheim | $274.00 | $239.43 | TheFly | Universal Health price target raised to $274 from $253 at Guggenheim |
| November 3, 2025 9:05 am | John Ransom | Raymond James | $270.00 | $217.01 | StreetInsider | Raymond James Upgrades Universal Health Services (UHS) to Outperform |
| October 30, 2025 1:31 pm | — | UBS | $231.00 | $225.30 | TheFly | Universal Health price target raised to $231 from $206 at RBC Capital |
| October 30, 2025 1:10 pm | Ben Hendrix | RBC Capital | $231.00 | $223.61 | StreetInsider | Universal Health Services (UHS) PT Raised to $231 at RBC Capital |
| October 29, 2025 1:06 pm | — | UBS | $302.00 | $219.32 | TheFly | Universal Health price target raised to $302 from $280 at UBS |
| October 29, 2025 10:42 am | Jason Cassorla | Guggenheim | $253.00 | $219.32 | TheFly | Universal Health price target raised to $253 from $227 at Guggenheim |
| October 29, 2025 9:37 am | Craig Hettenbach | Morgan Stanley | $233.00 | $219.32 | StreetInsider | Universal Health Services (UHS) PT Raised to $233 at Morgan Stanley |
Latest News for UHS
Universal Health Services, Inc. (UHS) Presents at TD Cowen 46th Annual Health Care Conference Transcript
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
UHS' Q4 EPS misses estimates despite a 19.5% jump, as softer admissions and rising costs weighed on results even as revenues climbed 9.1%.
Q4 2025 Revenue Growth: 9% increase.Q4 2025 Adjusted EBITDA Net of NCI: 10% increase.Q4 2025 Adjusted EPS: 20% increase compared to Q4 2024.Full Year 2025 Reve
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for UHS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.